- Ginsenoside Rg4
-
- $426.00
-
2026-07-15
- CAS:126223-28-7
- Purity: 99.17%
- Supply Ability: 10g
- (6β,8ξ,9ξ,12α,13α,14β,17β)-4-Ethyl-3,12-dihydroxy-4,10,14-trimeth yl-17-[(2Z)-6-methyl-2,5-heptadien-2-yl]gonan-6-yl 2-O-(6-deoxy-α -L-mannopyranosyl)-β-D-glucopyranoside
-
![(6β,8ξ,9ξ,12α,13α,14β,17β)-4-Ethyl-3,12-dihydroxy-4,10,14-trimeth yl-17-[(2Z)-6-methyl-2,5-heptadien-2-yl]gonan-6-yl 2-O-(6-deoxy-α -L-mannopyranosyl)-β-D-glucopyranoside pictures](https://img.chemicalbook.com/ProductImageEN/2020-2/Small/63a3b948-0563-4c3c-9a37-5a6b33b5c685.jpg)
- $9.80
-
2020-02-11
- CAS:126223-28-7
- Min. Order: 1g
- Purity: ＞98%
- Supply Ability: 20 tons
|
| | ginsenoside RG4 Basic information |
| Product Name: | ginsenoside RG4 | | Synonyms: | Ginsenosi Rg4;ginsenoside RG4;(6β,8ξ,9ξ,12α,13α,14β,17β)-4-Ethyl-3,12-dihydroxy-4,10,14-trimeth yl-17-[(2Z)-6-methyl-2,5-heptadien-2-yl]gonan-6-yl 2-O-(6-deoxy-α -L-mannopyranosyl)-β-D-glucopyranoside;delta20-Ginsenoside Rg2;b-D-Glucopyranoside, (3b,6a,12b,20Z)-3,12-dihydroxydammara-20(22),24-dien-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-;β-D-Glucopyranoside, (3β,6α,12β,20Z)-3,12-dihydroxydammara-20(22),24-dien-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-;wound,Ginsenoside Rg4,inhibit,ginsenoside,anti-diabetic,anti-antioxidant,Protopanaxatriol,Ginsenoside Rg-4,type,immune-stimulatory,Inhibitor,Bacterial,healing,Ginsenoside Rg 4,anti-septic;Ginsenoside Rg4, 10 mM in DMSO | | CAS: | 126223-28-7 | | MF: | C42H70O12 | | MW: | 767 | | EINECS: | | | Product Categories: | | | Mol File: | 126223-28-7.mol |  |
| | ginsenoside RG4 Chemical Properties |
| Boiling point | 851.6±65.0 °C(Predicted) | | density | 1.28±0.1 g/cm3(Predicted) | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 12.85±0.70(Predicted) | | color | White to off-white | | Cosmetics Ingredients Functions | ANTIOXIDANT |
| | ginsenoside RG4 Usage And Synthesis |
| Uses | 20(Z)-Ginsenoside F4 is isolated from Panax notoginseng which possesses therapeutic potential for cardiovascular disorders. | | Definition | ChEBI: (20E)-Ginsenoside F4 is a triterpenoid saponin. |
| | ginsenoside RG4 Preparation Products And Raw materials |
|